APA (7th ed.) Citation

L, v. W., A, S., M, W., M, W., M, M., S, G., . . . N, G. (2026). mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR+/HER2- breast cancer. Cell death & disease, 17(1), . https://doi.org/10.1038/s41419-026-08496-5

Chicago Style (17th ed.) Citation

L, von Wichert, et al. "MTOR-driven Autophagy Suppression Defines Metabolic Vulnerability in CDK4/6 Inhibitor-resistant HR+/HER2- Breast Cancer." Cell Death & Disease 17, no. 1 (2026). https://doi.org/10.1038/s41419-026-08496-5.

MLA (9th ed.) Citation

L, von Wichert, et al. "MTOR-driven Autophagy Suppression Defines Metabolic Vulnerability in CDK4/6 Inhibitor-resistant HR+/HER2- Breast Cancer." Cell Death & Disease, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41419-026-08496-5.